489 results on '"Fleischhacker, W. W."'
Search Results
2. New Developments in the pharmacotherapy of schizophrenia
3. Drug Treatment of Patients with Schizophrenia
4. Spätdyskinesien bei ambulanten Patienten in einem Psychiatrischen Gemeindezentrum: Prävalenz und Risikofaktoren
5. Emotional intelligence and non-social cognition in schizophrenia and bipolar I disorder
6. Steroidinduzierte Psychosen
7. Pharmakotherapie schizophrener Störungen
8. Measurement of neopterin, kynurenine and tryptophan in sera of schizophrenic patients
9. Drug Treatment for Patients with Schizophrenia — A Balance of the Century
10. (Sogenannte) Atypische Neuroleptika (Antipsychotika)
11. Extrapyramidal side-effects and prediction of neuroleptic treatment response
12. Clozapin — Dosierung und Plasmaspiegel
13. Dosissteigerung und parenterale Applikation von Antipsychotika bei therapieresistenten schizophrenen Patienten
14. Der Einfluß von Rauchen und Geschlecht auf die Dosis-Plasmaspiegel-Korrelation von Clozapin
15. Carbamazepin in der Prophylaxe der unipolaren Depression
16. Amitriptylin- und Nortriptylin-Plasmaspiegel nach der ersten Amitriptylingabe — ein Prädiktor für den Therapieerfolg?
17. Immunologische Probleme bei Opiatabhängigen
18. Veränderung von Neuropeptiden im Liquor cerebrospinalis schizophrener Patienten
19. Methodische Aspekte der Durchführung von Langzeitstudien mit schizophrenen Patienten
20. Die neuroleptische Langzeittherapie schizophrener Psychosen: Einstellungen und Richtlinien
21. Guidelines for Neuroleptic Relapse Prevention in Schizophrenia: Towards a Consensus View
22. Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents
23. Gewichtszunahme während der Behandlung mit Clozapin
24. Prädiktoren für die Langzeiteinnahme von Benzodiazepinen
25. Veränderungen von T-Lymphozyten Subsets bei schizophrenen Patienten
26. Austria: The Current Status of Maintenance Treatment in Schizophrenia
27. Hyperprolactinemia in antipsychotic-naive patients with first-episode psychosis
28. Pharmakotherapie der Schizophrenie
29. Correlates of subjective and functional outcomes in outpatient clinic attendees with schizophrenia and schizoaffective disorder
30. Olanzapine impairs glycogen synthesis and insulin signaling in L6 skeletal muscle cells
31. Unmet needs in patients with first-episode schizophrenia: a longitudinal perspective
32. Symptomatic remission and neurocognitive functioning in patients with schizophrenia
33. COGNITIVE TRAINING AND TREATMENT OUTCOME IN ALCOHOL DEPENDENCE: P322
34. Time after bone marrow transplantation as an important variable for quality of life: results of a cross-sectional investigation using two different instruments for quality-of-life assessment
35. Eisenbahnsuizide und -suizidversuche in Österreich von 1990–1994 Erweiterung der Hypothese medialer Vermittlung suizidalen Verhaltens: Erweiterung der Hypothese medialer Vermittlung suizidalen Verhaltens
36. COGNITIVE FUNCTIONING AND DEPRESSIVE SYMPTOMS IN ALCOHOL DEPENDENCE: 664
37. Does eosinophilia predict clozapine induced neutropenia?
38. New Developments in the pharmacotherapy of schizophrenia
39. Subjective response and attitudes toward antipsychotic drug therapy during the initial treatment period: a prospective follow-up study in patients with schizophrenia
40. Metabolic side effects of antipsychotic medication
41. Patterns of social distance towards people suffering from schizophrenia in Austria: a comparison between the general public, relatives and mental health staff
42. Differential effects of the D1-DA receptor antagonist SCH39166 on positive and negative symptoms of schizophrenia
43. Extrapyramidal side effects of clozapine and haloperidol
44. Clozapin in der Schwangerschaft: Medikamentenkonzentrationen in mütterlichem und fötalem Plasma, Fruchtwasser und Muttermilch
45. Neuronal correlates of sleep-dependent declarative memory consolidation: P476
46. Sleep-dependent memory consolidation in patients with schizophrenia: P483
47. Negative symptoms in schizophrenia: considerations for clinical trials: Working group on negative symptoms in schizophrenia
48. Measurement of neopterin, kynurenine and tryptophan in sera of schizophrenic patients
49. The Hillside Akathisia Scale: a reliability comparison of the English and German versions
50. Characteristics of benzodiazepine long-term users: investigation of benzodiazepine consumers among pharmacy customers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.